Vilnius-based Biomatter raises €16.2 million to make AI-designed custom enzymes not found in nature

In breve · dalla fonte (EU-Startups)

Di cosa si tratta

Biomatter, a Vilnius-based custom enzyme design company that delivers catalysts to solve real-world problems across industries, today announced the closing of an oversubscribed €16.2 million ($18 million) Series A financing. The round was led by Astanor, with participation from existing investors UVC Partners, Inventure, and Metaplanet. In August 2024, the company announced it had secured […] The post Vilnius-based Biomatter raises €16.2 million to make AI-designed custom enzymes not found in nature appeared first on EU-Startups .

Anteprima pubblicata dalla testata nel proprio feed. DuoBiz non ripubblica l'articolo né le immagini: per il testo completo, i dati e le dichiarazioni vai alla fonte.